Differentiating Characteristics of Patients Seeking a Second Opinion: A Survey on Non-Small Cell Lung Cancer Patients

被引：0
|
作者：
Leonard, K. [1 ]
Robertson, C. [1 ]
Hayes, S. [1 ]
McNamara, K. [1 ]
机构：
[1] Hlth Union Llc, Philadelphia, PA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
stigma among ever-smokers; second-opinion seeking; patient-provider relationship;
D O I：
10.1016/j.jtho.2018.08.1456
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.15-15
引用
收藏
页码：S822 / S823
页数：2
相关论文
共 50 条
  • [21] Clinical characteristics of patients with non-small cell lung cancer eligible for biologyguided radiotherapy
    Olaechea, Santiago
    Song, Tidie
    Gilmore, Linda
    Infante, Rodney E.
    Westover, Kenneth D.
    Zhang, Yuanyuan
    Desai, Neil B.
    Dan, Tu
    Timmerman, Robert D.
    Oz, Orhan K.
    Iyengar, Puneeth
    Garant, Aurelie
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Characteristics and outcomes of ALK plus non-small cell lung cancer patients in Korea
    Lim, Sung Hee
    Yoh, Kyung Ah
    Lee, Jong Seok
    Ahn, Myung-ju
    Kim, Yu Jung
    Kim, Se Hyun
    Zhang, Jie
    Patel, Dony
    Swallow, Elyse
    Kageleiry, Andrew
    Galebach, Philip
    Lee, Dongyeol
    Stein, Karen
    Degun, Ravi
    Park, Keunchil
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) : E239 - E245
  • [23] Genomic characteristics of driver genes in Chinese patients with non-small cell lung cancer
    Si, Xiaoyan
    Pan, Ruili
    Ma, Shaohua
    Li, Lin
    Liang, Li
    Zhang, Ping
    Chu, Yuping
    Wang, Hanping
    Wang, Mengzhao
    Zhang, Xiaotong
    Zhang, Li
    THORACIC CANCER, 2021, 12 (03) : 357 - 363
  • [24] NRAS mutated non-small cell lung cancer (NSCLC) patients: Characteristics and outcomes
    Dehem, A.
    Mazieres, J.
    Chour, A.
    Guisier, F.
    Ferreira, M.
    Boussageon, M.
    Girard, N.
    Moro-Sibilot, D.
    Cadranel, J.
    Zalcman, G.
    Ricordel, C.
    Wislez, M.
    Munck, C.
    Poulet, C-H.
    Gauvain, C.
    Descarpentries, C.
    Wasielewski, E.
    Cortot, A. B.
    Baldacci, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1023 - S1024
  • [25] Clinical Characteristics and Outcomes of Patients with BRAF Mutated Non-Small Cell Lung Cancer
    Mu, Y.
    Xing, P.
    Li, Y.
    Hao, X.
    Ying, J.
    Li, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S868 - S868
  • [26] Effect of second primary cancer on the prognosis of patients wit h non-small cell lung cancer
    Wu, Bingqun
    Cui, Yong
    Tian, Jintao
    Song, Xiaoping
    Hu, Pengcheng
    Wei, Shenhai
    JOURNAL OF THORACIC DISEASE, 2019, 11 (02) : 573 - 582
  • [27] Levels of serum bilirubin in small cell lung cancer and non-small cell lung cancer patients
    Jiang, Da
    Shi, Jian
    Yuan, Meng
    Duan, Xiaoyang
    Li, Lihua
    Li, Qian
    CELLULAR AND MOLECULAR BIOLOGY, 2018, 64 (06) : 71 - 76
  • [28] Opinion on influence of erythropoietin on quality of life and survival in patients with advanced non-small cell lung cancer
    Zemelka, Tomasz
    Rolski, Janusz
    Ziobro, Marek
    Michalczyk, Agnieszka
    WSPOTCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2007, 11 (01): : 37 - 40
  • [29] EFFICIENCY OF EXPENSES OF GEFITINIBUM IN PATIENTS WITH NON-SMALL CELL LUNG CANCER AS A SECOND LINE THERAPY
    Rudakova, A., V
    Meshkov, D. O.
    Khabriev, R. U.
    Bezmelnitsyna, L. Y.
    VALUE IN HEALTH, 2015, 18 (07) : A464 - A465
  • [30] Second-line chemotherapy in relapsing or refractory patients with non-small cell lung cancer
    Georgoulias, VA
    LUNG CANCER, 2002, 38 : S61 - S66
12345